COVID-19 vaccination in India: we need equity | BMJ Global Health blog
India needs a COVID-19 vaccination policy which has equity in its heart and souls , writes Soumyadeep Bhaumik.
Related Articles
The harms of class imbalance corrections for machine learning…
Risk prediction models are increasingly used in healthcare to aid in clinical decision making. In most clinical contexts, model calibration (i.e., assessing the reliability of…
String of killings have put spotlight on adequacy of mental health care in UK
Hainault attack may be latest incident linked to mental ill-health, at a time when NHS services are struggling
Silence about disabled doctors is a political statement in itself: the solution is intersectionality? By Prof. Shibley Rahman – The official blog of BMJ Leader
“The way we imagine discrimination or disempowerment often is more complicated for people who are subjected to multiple forms of exclusion. The good news is…
Data Science Experiences and Emotions: From Lonesome to Awesome · Issue 6.2, Spring 2024
Issue 6.2 / Spring 2024
Decoding Randomized Controlled Trials: An Information Science Perspective · Harvard Data Science Review
Published on Apr 30, 2024 DOI Column Editor’s Note: Randomized controlled trials (RCTs) are regarded as a form of ‘gold-standard’ for causal inferences in real-world…
Premarket Evidence and Postmarketing Requirements for RTOR Indication Approvals
This cross-sectional study evaluates the use of the US Food and Drug Administration’s Real-Time Oncology Review (RTOR) program in confirming the effectiveness of cancer drugs.
Frontiers | Confirmation bias and quantitative approach in psychiatry: should ideological competing interests be declared?
1 ADDIPSY, Outpatient Addictology and Psychiatry Center, Sant é Basque D é veloppement Group, Lyon, France 2 Universit é Paris-Saclay, Universit é de Versailles Saint-Quentin-en-Yvelines…
Warning over ‘severe’ weight-loss jab side effects
Semaglutide and liraglutide are sold under the brand names Wegovy, Ozempic, Rybelsus and Saxenda and are manufactured by Novo Nordisk
USPSTF Recommendation: Screening for Breast Cancer
This 2024 Recommendation Statement from the US Preventive Services Task Force recommends biennial screening mammography for women aged 40 to 74 years (B recommendation) and…
USPSTF Recommendation: Screening for Breast Cancer
This 2024 Recommendation Statement from the US Preventive Services Task Force recommends biennial screening mammography for women aged 40 to 74 years (B recommendation) and…